AzTrials
AzTrials

Penetrating Abdominal TraumaPAT-HMARNCT06228261

Critical Analysis of the Results in the Management of Penetrating Abdominal Trauma in the Past Fifteen Years.

An observational study of Penetrating Abdominal Trauma, run by Hospital del Mar.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Penetrating abdominal trauma (PAT) incidence varies between 3,1-12,8% and it comprises a wide range of injuries with varying patterns on diagnostic imaging. Last guidelines published in 2014 recommend the use of FAST and CXR as the Gold Standard method for evaluating. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Penetrating Abdominal Trauma
How many people
1,000 participants
Where
No sites listed yet
Study dates
15 Mar 2024to 15 Mar 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with a penetrating trauma in the neck admitted in Hospital del Mar from 2008 to 2023.

Who may be able to join

  • All penetrating trauma patients admitted in the emergency department.

Who cannot join

  • All patients with any other diagnostic different from penetrating trauma
  • Blunt trauma patients admitted in the emergency department

Trial locations and contacts

No sites are listed yet.

Ana María González Castillo, PhD contact

+34665126866

amgonzalezcastillo@gmail.com

About this study

Official title: Critical Analysis of the Results in the Management of Penetrating Abdominal Trauma in the Past Fifteen Years. Do we Need to Change the Protocol?

Penetrating abdominal trauma (PAT) incidence varies between 3,1-12,8% and it comprises a wide range of injuries with varying patterns on diagnostic imaging. Last guidelines published in 2014 recommend the use of FAST and CXR as the Gold Standard method for evaluating. Computed Tomography (CT) is widely used in stable patients with PAT and it requires intravenous contrast and patient irradiation, leading to additional costs to healthcare services. This study aims to assess the management of PAT in our institution and with its results review the actual protocol.

Read the detailed description

Penetrating abdominal trauma (PAT) incidence varies between 3,1-12,8% and it comprises a wide range of injuries with varying patterns on diagnostic imaging. Last guidelines published in 2014 recommend the use of FAST and CXR as the Gold Standard method for evaluating. Computed Tomography (CT) is widely used in stable patients with PAT and it requires intravenous contrast and patient irradiation, leading to additional costs to healthcare services. This study aims to assess the management of PAT in our institution and with its results review the actual protocol.

A retrospective unicentric study will be conducted on a prospective database of stab wounds at the Department of General Surgery of Hospital del Mar over a 15-year period. The normality of the distribution of quantitative variables will be assessed using the Kolmogorov-Smirnov test. Comparison between qualitative variable groups will be performed using the Chi-square test or Fisher's exact test when appropriate, and non-parametric tests like the Mann-Whitney U test will be used to evaluate the significance of differences in means of quantitative variables. The odds ratios (OR) of predictor variables with outcome variables will be determined.

Keywords
Penetrating Trauma, Trauma surgery, Explorative laparoscopy, Trauma laparotomy, eFAST

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Complications

    The main outcome measure was the total of complications in patients with a penetrating abdominal trauma assessed by the Clavien-Dindo Classification.

    Measured: 2008-2023

  2. Mortality

    The second main outcome measure was the total of deaths in patients with a penetrating abdominal trauma assessed by preventable or non-preventable deaths.

    Measured: 2008-2023

Secondary outcomes (4)
  1. Explorations

    To describe the explorations that has been ordered: eFAST, CT Scan, explorative laparoscopy or laparotomy.

    Measured: 2008-2023

  2. Demographyc description

    Description of the age and gender (Male / Female)

    Measured: 2008-2023

  3. Physiologic description

    Description of the vitals at arrival (bates per minute, blood pressure)

    Measured: 2008-2023

  4. Wound and abdominal exploration

    Description of the wound: bleeding, longitude, number of wounds and the abdominal explorations: peritonism or no peritonism.

    Measured: 2008-2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2024
  2. Study start15 Mar 2024 (estimated)
  3. Primary completion15 Dec 2024 (estimated)
  4. Study completion15 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06228261
Sponsor's protocol ID
Penetrating abdotrauma HMAR
Acronym
PAT-HMAR
Status last verified
Jan 2024
First submitted
18 Jan 2024
Last updated
29 Jan 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Penetrating Abdominal Trauma, run by Hospital del Mar.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ana María González Castillo, PhD (+34665126866, amgonzalezcastillo@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Complications (time frame: 2008-2023). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in